News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.
Gov. Andrew Cuomo signed into law a bill extending the authority of pharmacists and nurse practitioners to administer certain immunizations as of July 1. The bill comes after a surge in whooping cough cases in New York, which began in 2013.
The FDA announced on Tuesday that it determined that partially hydrogenated oils, the primary dietary source of artificial trans fat in processed foods, are not generally recognized as safe for use in human food.
Loblaw has announced that by the end of 2018, its private brands Life Brand and President's Choice household, beauty and cosmetic products will no longer be formulated using triclosan, phthalates or micro beads.
On June 13th at the Cabell County Public Library, Brad Hodges president of the National Federation of the Blind of West Virginia, Huntington Area Chapter, will join Drew Massey, clinical services coordinator for Fruth Pharmacy in demonstrating a new audio prescription label.
Efficient Collaborative Retail Marketing just did an unconventional acquisition to provide the company with a new source of growth by applying its successful model of connecting buyers and sellers to the media world.
Tooth decay is one of the most common chronic conditions among children in the United States, according to the Centers for Disease Control and Prevention, with about 20% of children ages 5 years to 11 years old having at least one untreated decayed tooth. The good news is that tooth decay is preventable.
The National Association of Chain Drug Stores has submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health expressing concerns about pharmacy-related budget proposals.
Mylan has been appointed as the exclusive India distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, by Gilead Sciences.
As part of its ongoing exploration of how pharmacists can engage in interdisciplinary efforts to promote oral health, the American Pharmacists Association Foundation has teamed up with America’s ToothFairy: National Children’s Oral Health Foundation.